Skip to main content
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: Cephalalgia. 2016 Jul 11;37(2):161–176. doi: 10.1177/0333102416641665

Table 2.

Clinical outcomes before and after treatment in different groups. AG, acupuncture group including both verum acupuncture and sham acupuncture; VA, verum acupuncture; SA, sham acupuncture group; SAS, self-rating anxiety scale; SDS, self-rating depression scale; WT, waiting list. Pair-t test was applied for comparisons in each group.

Outcome measures VA1, n=12 VA2, n=14 VA3, n=15 SA, n=13 WT, n=18 AG, n=54

Headache intensity
Mean (95%CI)

Baseline 5.33 5.32 5.80 5.46 5.58 5.49
(4.46; 6.20) (4.77; 5.87) (5.20; 6.40) (4.52; 6.40) (5.14; 6.03) (5.15; 5.83)

End of treatment 3.25 3.57 2.87 4.19 5.53 3.45
(2.39; 4.11) (2.83; 4.31) (2.01; 3.72) (3.34; 5.04) (4.69; 6.36) (3.06; 3.85)

P value 0.003 0.000 0.000 0.083 0.869 0.000

Headache frequency
Mean (95%CI)

Baseline 5.75 7.50 5.73 6.00 4.50 6.26
(3.89; 7.61) (5.61; 9.39) (3.58; 7.88) (4.04; 7.96) (3.07; 5.93) (5.34; 7.18)

End of treatment 3.92 5.93 4.20 6.15 8.17 5.06
(2.37; 5.46) (4.38; 7.47) (2.42; 5.98) (4.03; 8.27) (5.81; 10.52) (4.21; 5.90)

P value 0.014 0.021 0.013 0.895 0.001 0.003

SAS score
Mean (95%CI)

Baseline 44.63 44.86 47.02 47.21 47.10 46.00
(39.74; 49.51) (40.36; 49.35) (41.69; 52.34) (42.23; 52.20) (41.92; 52.26) (43.71; 48.23)

End of treatment 38.13 41.45 37.98 37.37 41.39 38.76
(31.15; 45.10) (37.12; 45.78) (32.61; 43.36) (33.09; 41.64) (37.83; 44.94) (36.36; 41.17)

P value 0.055 0.117 0.005 0.019 0.017 0.000

SDS score
Mean (95%CI)

Baseline 42.13 48.98 44.80 45.06 46.88 45.35
(35.01; 49.24) (43.97; 53.99) (38.22; 51.38) (39.25; 50.86) (42.01; 51.74) (42.51; 48.20)

End of treatment 40.63 42.68 39.15 37.56 41.18 40.01
(32.17; 49.08) (37.07; 48.28) (33.41; 44.89) (32.06; 43.06) (36.57; 45.80) (37.14; 42.88)

P value 0.518 0.040 0.023 0.049 0.066 0.000